Breakdown | TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 123.58M | 127.75M | 111.35M | 103.73M | 103.97M | 119.67M |
Gross Profit | 59.27M | 62.23M | 46.81M | 37.69M | 33.95M | 50.41M |
EBITDA | 39.44M | 46.60M | 31.54M | 19.10M | 33.97M | 23.33M |
Net Income | 29.65M | 31.23M | 19.30M | 10.43M | 26.55M | 4.25M |
Balance Sheet | ||||||
Total Assets | 159.44M | 157.45M | 145.30M | 151.85M | 128.26M | 118.56M |
Cash, Cash Equivalents and Short-Term Investments | 81.81M | 62.52M | 73.12M | 56.43M | 54.83M | 34.84M |
Total Debt | 0.00 | 27.00K | 178.00K | 0.00 | 0.00 | 1.62M |
Total Liabilities | 16.99M | 14.97M | 20.35M | 31.51M | 13.81M | 19.13M |
Stockholders Equity | 141.10M | 141.34M | 124.23M | 119.88M | 114.26M | 99.45M |
Cash Flow | ||||||
Free Cash Flow | 20.88M | 2.11M | 30.79M | 7.82M | 22.09M | 10.40M |
Operating Cash Flow | 25.23M | 6.46M | 34.24M | 23.95M | 32.63M | 12.55M |
Investing Cash Flow | -1.58M | -2.50M | -3.05M | -17.55M | 1.42M | -926.00K |
Financing Cash Flow | -14.43M | -14.56M | -14.53M | -4.80M | -14.25M | -14.86M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
80 Outperform | HK$270.22B | 16.58 | 25.82% | ― | 9.42% | 33.34% | |
74 Outperform | HK$136.80M | 4.61 | 22.27% | 14.04% | 11.81% | 49.64% | |
71 Outperform | $37.23B | 10.21 | 8.59% | 5.83% | 20.21% | 23.24% | |
63 Neutral | HK$418.03M | 7.52 | 12.01% | ― | 25.55% | 14.47% | |
56 Neutral | $3.16B | 5.05 | -5.68% | 5.76% | 8.05% | -41.83% | |
47 Neutral | HK$42.40M | ― | -10.42% | 9.43% | -20.08% | -44.11% |